Moreover, NOTCH1 loss-of-function mutations were found to specifically promote tumour persistence in sporadic BCCs suggesting therapeutic restoring of the NOTCH tumour-suppressor function as a potential approach to eradicate persistent tumour cells40. The gene discussed is NOTCH1; the disease is neoplasm.